Subscribe To
CymaBay Announces Pricing of Upsized $225 Million Public Offering of Common Stock and Pre-Funded Warrants
NEWARK, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing innovative therapies for liver and other chronic diseases with high unmet medical need, today announced the pricing of its previously announced underwritten public offering of common stock and pre-funded warrants. CymaBay is selling 12,551,080 shares […] The post CymaBay Announces Pricing of Upsized $225 Million Public Offering of Common St...
Read More
Posted: Sep 12 2023, 02:15
Author Name: forextv
Views: 112526